StonvexLoading…
StonvexStonvexStonvexCore line items from THRM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-22 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $390.33M | $393.71M | $1.50B | $1.12B | $728.94M |
Operating Income | Not available | $11.29M | $82.70M | $64.93M | $41.07M |
Net Income | Not available | $4.22M | $18.29M | $15.30M | $477.00K |
EPS (Diluted) | $0.57 | $0.14 | $0.59 | $0.50 | $0.01 |
Total Assets | Not available | $1.43B | $1.40B | $1.38B | $1.36B |
Total Liabilities | Not available | $713.82M | $676.11M | $663.39M | $661.66M |
Cash & Equivalents | Not available | $177.40M | $160.83M | $154.25M | $128.30M |
Free Cash Flow OCF − CapEx | Not available | $-10.69M | $61.12M | $54.44M | $7.97M |
Shares Outstanding | Not available | 30.67M | 30.53M | 30.53M | 30.52M |